Nona Biosciences, leveraging its proprietary Harbour Mice® platform, excels in therapeutic antibody discovery, offering end-to-end solutions from target validation to preclinical research. Their technology fosters the creation of fully human monoclonal antibodies, driving the invention of next-generation drugs globally. #TherapeuticAntibody #BiotechInnovation Discover more about https://www.nonabio.com/en/newsd6.html.
Nona Biosciences, leveraging its proprietary Harbour Mice® platform, excels in therapeutic antibody discovery, offering end-to-end solutions from target validation to preclinical research. Their technology fosters the creation of fully human monoclonal antibodies, driving the invention of next-generation drugs globally. #TherapeuticAntibody #BiotechInnovation Discover more about https://www.nonabio.com/en/newsd6.html.
0 Comments
0 Shares